Strategic Alliances: a Portfolio of Technologies and Services

Non-Equity Contract Development Alliance with Explicat Pharma GmbH and CBA GmbH

Complex and long-term development projects often require a proper CMC management, proven regulatory expertise (PAT submissions) and GMP analytics. Currently, the strongest interdisciplinary relationship GILYOS can revert to is a non-equity contract development alliance with Explicat Pharma GmbH and CBA GmbH to better serve your development needs and align with your development objectives. This historically evolved alliance allows us to offer our services from early API research / pre-formulation development to final product manufacturing, and beyond.

Non-Equity Contract Development Alliance


Three strong partners provide a portfolio of technologies and services to support your drug product development and regulatory submission: GILYOS GmbH, Explicat Pharma GmbH and CBA GmbH.